Clinical Trial Update: Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating losartan in combination with paclitaxel for platinum-resistant ovarian cancer; recruitment has not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Losartan (losartan)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Platinum Resistant Ovarian Cancer | Phase 2 | Status: NOT_YET_RECRUITING